Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects

Antiviral Research

Volumn 29, Issue 2-3, 1996, Pages 153-161

  Wachsman, M ^a   Petty, B G ^a   Cundy, K C ^b   Jaffe, H S ^b   Fisher, P E ^b   Pastelak, A ^a   Lietman, P S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GILEAD SCIENCES   (United States)

Author keywords

antiviral; bioavailability; cidofovir; clinical trial; cytomegalovirus

Indexed keywords

CIDOFOVIR; PLACEBO; ZIDOVUDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029991161     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00829-2     Document Type: Article

References (16)

1. Anderson, S., Diamond, J.R., Karnovsky, M.J. and Brenner, B.M. (1991) Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome. J. Clin. Invest. 82, 1757-1768.
2. Chan, T.C.K , Shaffer, L., Redmond, R. and Pennington, K.L. (1993) Permeation and metabolism of anti-HIV and endogenous nucleosides in human immune effector cells. Biochem. Pharm. 46, 273-278.
3. Cundy, K.C., Petty, B.C., Flaherty, J., Fisher, P.E., Polis, M.A., Wachsman, M., Lietman, P.S., Lalezari, J.P., Hitchcock, M.J.M. and Jaffe, H.S. (1995) Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 39, 1247-1252.
4. Eddy, A.A., McCulloch, L., Liu, E. and Adams, J. (1991) A relationship between proteinuria and acute tubulointerstitial disease in rats with experimental nephrotic syndrome. Am. J. Pathol. 138, 1111-1123.
5. Gentry, G.A. (1992) Viral thymidine kinases and their relatives. Pharm. Ther. 54, 319-355.
6. Grieco, A. and Long, C.L. (1984) Investigation of the Karnofsky performance status as a measure of quality of life. Health Psych. 6, 129-142.
7. Ho, H.-T., Woods, K.L., Bronson, J.J., De Boeck, H., Martin, J.C. and Hitchcock, M.J.M. (1992) Intracellular metabolism of the antiherpes agent (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl] cytosine. Mol. Pharmacol. 41, 197-202.
8. Hoyer, J.R., Ratte, J., Potter, A.H. and Michael, A.F. (1972) Transfer of aminonucleoside nephrosis by renal transplantation. J. Clin. Invest. 51, 2777-2780.
9. Kowalski, K.G. (1994) An algorithm for estimating the terminal half-life in pharmacokinetic studies. Comput. Methods Prog. Biomed. 42, 119-126.
10. Nahman, N.S. Jr. and Cosio, F.G. (1990) The effects of cyclosporin in experimental glomerulosclerosis. Nephron. 56, 414-420.
11. Neyts, J., Snoeck, R., Balzarini, J. and De Clercq, E. (1991) Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl] cytosine (HPMPC) in vitro. Antivir. Res. 16, 41-52.
12. Polis, M.A., Spooner, K.M., Baird, B.F., Manischewitz, J.F., Jaffe, H.S., Fisher, P.E., Fallon, J., Davey, Jr., R.T., Kovacs, J.A., Walker, R.E., Whitcup, S.M., Nussenblatt, R.B., Lane, H.C. and Masur, H. (1995) Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob. Agents Chemother. 39, 882-886.
13. Rowland, M. and Tozer, T.N. (1989) Clinical Pharmacokinetics: Concepts and Application, 546 pp. Lea and Febiger, Philadelphia.
14. Shargel, L. and Yu, A.B.C. (1985) Applied Biopharmaceutics and Pharmacokinetics, 430 pp. Appleton Century-Crofts, Norwalk.
15. Stonard, M.D., Gore, C.W., Oliver, G.J.A. and Smith, I.K. (1987) Urinary enzymes and protein patterns as indicators of injury to different regions of the kidney. Fundam. Appl. Tox. 9, 339-351.
16. Tune, B.M., Fravert, D. and Hsu, C.-Y. (1989) Thienamycin nephrotoxicity mitochondrial injury and oxidative effects of imipenem in the rabbit kidney. Biochem. Pharmacol. 21, 3779-3783.